CompletedNCT04988178
Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.
Phase not reported · 34 planned enrolment
- Countries listed
- 1
- Registry update
- March 21, 2022
